News
The Genetic Architecture of Congenital Diarrhea and Enteropathy - (https://www.nejm.org/doi/10.1056/NEJMoa2405333) ...
Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, dose optimization and rational therapeutic ...
5d
Investor's Business Daily on MSNThis IBD 50 Stock Holds Base Amid Massive Tariff Sell-OffIBD 50 stock Enova International is holding up in a base. That shows that its uptrend is still intact for now amid the tariff ...
Patients with Crohn’s disease had high Epstein-Barr virus seropositivity in the preclinical period and at diagnosis of inflammatory bowel disease, according to results of a cohort study of military ...
Two years after announcing that distributor HLC would handle its sales in the U.S., Norco Bicycles said it is resuming direct sales in July.Norco said the decision was by mutual agreement. Norco ...
6d
Investor's Business Daily on MSNIBD 50 Stock TG Therapeutics Rallies On A Setback For Chief Rival RocheTG Therapeutics rallied Wednesday after Roche's rival multiple sclerosis treatment, Ocrevus, missed its mark in a study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results